Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dicobalt edetate
Alliance Pharmaceuticals Ltd
n/a
Dicobalt edetate
15mg/1ml
Solution for injection
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 19020700; GTIN: 5024403000219
D ICOBALT E DETATE INJECTION 300 mg (Dicobalt edetate) READ ALL OF THIS LEAFLET CAREFULLY - This leaflet contains information about Dicobalt Edetate Injection, which will have already been given to you by injection into one of your veins. - Although you will not be taking this medicine yourself, this leaflet contains important information to help you understand how Dicobalt Edetate Injection is used. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse - If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse. IN THIS LEAFLET: 1. What Dicobalt Edetate Injection is and what it is used for 2. Before you are given Dicobalt Edetate Injection 3. How Dicobalt Edetate Injection is given 4. Possible side effects 5. How to store Dicobalt Edetate Injection 6. Further information 1. WHAT DICOBALT EDETATE INJECTION IS AND WHAT IT IS USED FOR Dicobalt Edetate Injection 300 mg is an antidote for cyanide poisoning which must be treated as quickly as possible. It is usually only given when the patient is, or becoming, unconscious. Dicobalt Edetate is a life-saving injection and will not be given as a precautionary measure. 2. BEFORE YOU ARE GIVEN DICOBALT EDETATE INJECTION THIS SOLUTION MUST NOT BE GIVEN IF: • the poisoning is so mild that the patient is fully conscious._ _ • the patient’s condition is not due to cyanide poisoning - the injection on its own is toxic._ _ TAKING OTHER MEDICINES There is no information available about the interaction of this injection with other medicines. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. PREGNANCY AND BREAST-FEEDING There is no information available about the use of this injection in pregnant or breast-feeding women. IMPORTANT INFORMATION ABOUT SOME OF THE INGREDIENTS IN DICOBALT EDETATE INJECTION DEXTROSE is an ingredient in the soluti Διαβάστε το πλήρες έγγραφο
OBJECT 1 DICOBALT EDETATE INJECTION 300MG Summary of Product Characteristics Updated 20-Feb-2012 | Alliance Pharmaceuticals 1. Name of the medicinal product Dicobalt Edetate Injection 300mg 2. Qualitative and quantitative composition Each ampoule contains 300mg Dicobalt Edetate INN (15mg/ml) 3. Pharmaceutical form Solution for Injection 4. Clinical particulars 4.1 Therapeutic indications Dicobalt Edetate Injection is a specific antidote for acute cyanide poisoning. In view of the difficulty of certain diagnosis in emergency situations, it is recommended that Dicobalt Edetate Injection only be given when the patient is tending to lose or has lost consciousness. The product should not be used as a precautionary measure. 4.2 Posology and method of administration Cyanide poisoning must be treated as quickly as possible and intensive supportive measures must be instituted: clear airways and adequate ventilation are essential. 100% oxygen should be administered concurrently with Dicobalt Edetate. Expert advice on the treatment of poisoning is available at the local poisons centre. Adults One 300mg ampoule intravenously over approximately one minute. If the patient shows inadequate response, a second ampoule may be given. If there is no response after a further five minutes, a third ampoule may be administered. Each ampoule of Dicobalt Edetate Injection may be followed immediately by 50ml Glucose Intravenous Infusion BP 500g/l. When the patient's condition is less severe but in the physician's judgement still warrants the use of Dicobalt Edetate Injection, the period over which the injection is given should be extended to 5 minutes. Children There is no clinical experience of the use of Dicobalt Edetate Injection in children. As with adults the dose required will be related to the quantity of cyanide ingested. The elderly There is no clinical evidence of the use of Dicobalt Edetate Injection in the elderly, but there is no reason to believe that the dosage schedule should be different from that for adults. 4.3 Contraind Διαβάστε το πλήρες έγγραφο